F S&P 500
5,536.50 +15.00 (+0.27%) F Dow Jones
39,527.00 +58.00 (+0.15%) F Nasdaq
19,994.00 +66.75 (+0.33%) E-mini Russell 2000 Index Futur
2,073.90 +8.90 (+0.43%) Petróleo
81.99 +0.45 (+0.55%) Oro
2,337.80 -1.80 (-0.08%)
MediPharm Labs Corp. (MEDIF)
MediPharm Labs Corp.
151 John Street
Barrie, ON L4N 2L1
Canada
705-719-7425
https://www.medipharmlabs.com
Sector(es): Healthcare
Industria: Drug Manufacturers - Specialty & Generic
Empleados a tiempo completo: 166
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. David A. Pidduck | CEO & Director | 514.71k | N/D | N/D |
| Mr. Keith Strachan | Co-Founder & President | 469.08k | N/D | N/D |
| Mr. Greg Hunter | Chief Financial Officer | 573.12k | N/D | N/D |
| Mr. Patrick McCutcheon | Founder | 626.53k | N/D | N/D |
| Mr. Brett Moon | Vice President of Sales | N/D | N/D | N/D |
| Mr. Kirk Binns | Executive Vice President of Global Accounts | N/D | N/D | N/D |
Descripción
MediPharm Labs Corp., a pharmaceutical company, engages in the production and sale of purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, processes, packages, and distributes cannabis active ingredients and advanced cannabinoid-based products. It also provides good manufacturing practice flower sourcing, packaging, and distribution services, as well as dried flower and pre-roll cannabis products. In addition, the company offers cannabis related medical information and services; and medical cannabis clinic services. MediPharm Labs Corp. was founded in 2015 and is headquartered in Barrie, Canada.
Gestión corporativa
La calificación ISS Governance QuickScore de MediPharm Labs Corp. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.
